Lai Wang

CIK 1852291 · President, Global Head of R&D · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.6K

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$9.18M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ONC President, Global Head of R&D 40 $264.48 $10.6K -$5.97M 12 2026-06-10
BeOne Medicines Ltd. (BGNE) Delisted Global Head of R&D 1,717,885 $184.71 $317.31M -$3.21M 16 2024-10-01

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-24 BeOne Medicines Ltd. (BGNE) Delisted Grant (A) +125,255 $0 EDGAR
2022-06-22 BeOne Medicines Ltd. (BGNE) Delisted Sell (S) −1,168 -$169.8K EDGAR
2022-06-08 BeOne Medicines Ltd. (BGNE) Delisted Sell (S) −660 -$93.7K EDGAR
2022-05-19 BeOne Medicines Ltd. (BGNE) Delisted Exer (M) +1,233,947 $4.03M EDGAR
2021-12-17 BeOne Medicines Ltd. (BGNE) Delisted Mixed −58,188 $0 EDGAR
2021-06-30 BeOne Medicines Ltd. (BGNE) Delisted Sell (S) −455 -$164.9K EDGAR
2021-06-21 BeOne Medicines Ltd. (BGNE) Delisted Mixed +52,823 -$265.6K EDGAR
2021-06-09 BeOne Medicines Ltd. (BGNE) Delisted Sell (S) −656 -$232.4K EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.